1. Unni KK. Dahlin's bone tumors: general aspects and data on 11,087 cases. 5th ed. Philadelphia: Lippincott-Raven;1996. p. 263–285.
2. Schajowicz F. Tumors and tumor-like lesions of bone: pathology, radiology, and treatment. 2nd ed. Berlin: Springer-Verlag;1994. p. 257–295.
3. Bertoni F, Unni KK, Beabout JW, Ebersold MJ. Giant cell tumor of the skull. Cancer. 1992; 70:1124–1132. PMID:
1515987.
Article
4. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol. 2001; 16:297–307. PMID:
11193206.
5. Huvos AG. Bone tumors: diagnosis, treatment and prognosis. Tumors of histiocytic or fibrohistiocytic origin. 2nd ed. Philadelphia: Saunders;1991. p. 429–467.
6. Robbins SL, Cotran RS, Kumar V. Robbins pathological basis of disease. 5th ed. Philadelphia: WB Saunders;1994. p. 1245–1246.
7. Vanel D, Contesso G, Rebibo G, Zafrani B, Masselot J. Benign giant-cell tumours of bone with pulmonary metastases and favourable prognosis. Report on two cases and review of the literature. Skeletal Radiol. 1983; 10:221–226. PMID:
6648560.
8. Leonard J, Gökden M, Kyriakos M, Derdeyn CP, Rich KM. Malignant giant-cell tumor of the parietal bone: case report and review of the literature. Neurosurgery. 2001; 48:424–429. PMID:
11220389.
Article
9. Min BI, Park YW. A case of metastatic giant cell tumor arising in two-year old girl. J Korean Assoc Oral Maxillofac Surg. 1988; 14:82–87.
10. Lee HJ, Lum C. Giant-cell tumor of the skull base. Neuroradiology. 1999; 41:305–307. PMID:
10344520.
Article
11. Morriss-Kay GM. Derivation of the mammalian skull vault. J Anat. 2001; 199:143–151. PMID:
11523816.
Article
12. Findlay JM, Chiasson D, Hudson AR, Chui M. Giant-cell tumor of the middle cranial fossa. Case report. J Neurosurg. 1987; 66:924–928. PMID:
3572521.
13. Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112:453–462. PMID:
21835653.
Article
14. Lee BK. Evidence-based practice in the treatment of temporomandibular disorders. J Korean Assoc Oral Maxillofac Surg. 2012; 38:263.
Article
15. Wang CS, Lou JH, Liao JS, Ding XY, Du LJ, Lu Y, et al. Recurrence in giant cell tumour of bone: imaging features and risk factors. Radiol Med. 2013; 118:456–464. PMID:
22872452.
Article
16. Purohit S, Pardiwala DN. Imaging of giant cell tumor of bone. Indian J Orthop. 2007; 41:91–96. PMID:
21139758.
Article
17. Wysocki RW, Soni E, Virkus WW, Scarborough MT, Leurgans SE, Gitelis S. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome. Clin Orthop Relat Res. 2015; 473:706–715. PMID:
25472928.
Article
18. Silvers AR, Som PM, Brandwein M, Chong JL, Shah D. The role of imaging in the diagnosis of giant cell tumor of the skull base. AJNR Am J Neuroradiol. 1996; 17:1392–1395. PMID:
8871731.
19. Chen ZX, Gu DZ, Yu ZH, Qian TN, Huang YR, Hu YH, et al. Radiation therapy of giant cell tumor of bone: analysis of 35 patients. Int J Radiat Oncol Biol Phys. 1986; 12:329–334. PMID:
2420770.
Article
20. Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res. 2012; 18:4415–4424. PMID:
22711702.
Article